ECOR vs. HSDT

Last updated Apr 1, 2026

Compare and contrast key facts about electroCore, Inc. (ECOR) and Helius Medical Technologies, Inc. (HSDT).

Performance

ECOR vs. HSDT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in electroCore, Inc. (ECOR) and Helius Medical Technologies, Inc. (HSDT). The values are adjusted to include any dividend payments, if applicable.

ECOR vs. HSDT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ECOR electroCore, Inc.	34.45%	-72.33%	172.35%	54.54%	-55.92%	-62.66%	-1.89%	-74.60%	-68.46%
HSDT Helius Medical Technologies, Inc.	-40.14%	-99.43%	-91.66%	-47.61%	-94.09%	-60.63%	-61.18%	-89.41%	-22.64%

Fundamentals

EPS ECOR : $0.00 HSDT : -$4.55
PS Ratio ECOR : 1.05 HSDT : 2.59
Total Revenue (TTM) ECOR : $32.03M HSDT : $6.02M
Gross Profit (TTM) ECOR : $27.79M HSDT : $5.52M
EBITDA (TTM) ECOR : $28.00K HSDT : -$243.84M

Returns By Period

In the year-to-date period, ECOR achieves a 34.45% return, which is significantly higher than HSDT's -40.14% return.

ECOR

• 1D: 6.91%
• 1M: -20.45%
• YTD: 34.45%
• 6M: 21.82%
• 1Y: -9.87%
• 3Y*: 3.11%
• 5Y*: -27.59%
• 10Y*: —

HSDT

• 1D: -6.99%
• 1M: -7.49%
• YTD: -40.14%
• 6M: -88.38%
• 1Y: -99.42%
• 3Y*: -94.34%
• 5Y*: -92.37%
• 10Y*: -73.53%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ECOR vs. HSDT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ECOR

ECOR Risk / Return Rank: 39
ECOR Sharpe Ratio Rank: 36
ECOR Sortino Ratio Rank: 42
ECOR Omega Ratio Rank: 41
ECOR Calmar Ratio Rank: 37
ECOR Martin Ratio Rank: 38

HSDT

HSDT Risk / Return Rank: 9
HSDT Sharpe Ratio Rank: 21
HSDT Sortino Ratio Rank: 1
HSDT Omega Ratio Rank: 2
HSDT Calmar Ratio Rank: 1
HSDT Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ECOR vs. HSDT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for electroCore, Inc. (ECOR) and Helius Medical Technologies, Inc. (HSDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ECOR	HSDT	Difference
Sharpe ratio Return per unit of total volatility	-0.11	-0.47	+0.36
Sortino ratio Return per unit of downside risk	0.49	-2.25	+2.74
Omega ratio Gain probability vs. loss probability	1.06	0.71	+0.35
Calmar ratio Return relative to maximum drawdown	-0.14	-1.00	+0.86
Martin ratio Return relative to average drawdown	-0.22	-1.11	+0.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ECOR vs. HSDT - Sharpe Ratio Comparison

The current ECOR Sharpe Ratio is -0.11, which is higher than the HSDT Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of ECOR and HSDT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ECOR	HSDT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.11	-0.47	+0.36
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.32	-0.59	+0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.37	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.31	-0.38	+0.07

Correlation

The correlation between ECOR and HSDT is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ECOR vs. HSDT - Dividend Comparison

Neither ECOR nor HSDT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ECOR vs. HSDT - Drawdown Comparison

The maximum ECOR drawdown since its inception was -98.95%, roughly equal to the maximum HSDT drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ECOR and HSDT.

Drawdown Indicators

	ECOR	HSDT	Difference
Max Drawdown Largest peak-to-trough decline	-98.95%	-100.00%	+1.05%
Max Drawdown (1Y) Largest decline over 1 year	-45.99%	-99.47%	+53.48%
Max Drawdown (5Y) Largest decline over 5 years	-89.88%	-100.00%	+10.12%
Max Drawdown (10Y) Largest decline over 10 years	—	-100.00%	—
Current Drawdown Current decline from peak	-97.97%	-100.00%	+2.03%
Average Drawdown Average peak-to-trough decline	-90.47%	-72.97%	-17.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	29.52%	89.49%	-59.97%

Volatility

ECOR vs. HSDT - Volatility Comparison

The current volatility for electroCore, Inc. (ECOR) is 23.18%, while Helius Medical Technologies, Inc. (HSDT) has a volatility of 26.58%. This indicates that ECOR experiences smaller price fluctuations and is considered to be less risky than HSDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ECOR	HSDT	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.18%	26.58%	-3.40%
Volatility (6M) Calculated over the trailing 6-month period	54.92%	96.11%	-41.19%
Volatility (1Y) Calculated over the trailing 1-year period	89.52%	212.62%	-123.10%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	87.44%	155.80%	-68.36%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	129.36%	200.11%	-70.75%

Financials